Health & Environmental Research Online (HERO)


Print Feedback Export to File
7087988 
Journal Article 
Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease) 
Lammer, J; Zeller, T; Hausegger, KA; Schaefer, PJ; Gschwendtner, M; Mueller-Huelsbeck, S; Rand, T; Funovics, M; Wolf, F; Rastan, A; Gschwandtner, M; Puchner, S; Ristl, R; Schoder, M; , 
2013 
Yes 
Journal of the American College of Cardiology
ISSN: 0735-1097
EISSN: 1558-3597 
Elsevier Science Ltd., The Boulevard Kidlington Oxford OX5 1GB United Kingdom 
New York 
62 
15 
1320-1327 
English 
23831445 
WOS:000325005000003 
The hypothesis that endovascular treatment with covered stents has equal risks but higher efficacy than bare-metal stents (BMS) in long femoropopliteal artery disease was tested. 
Toxicology Abstracts; angioplasty; covered stent; peripheral arterial disease; stent; stent graft; superficial femoral artery; ABI ankle-brachial index; BMS bare-metal stent(s); CI confidence interval; CDUS color-coded Doppler ultrasound; ePTFE expanded polytetrafluoroethylene; ITT intention-to-treat; PAD peripheral arterial disease; PTA percutaneous transluminal balloon angioplasty; RCT randomized controlled trial; SFA superficial femoral artery; TASC TransAtlantic Inter-Society Consensus; TLR target lesion revascularization; TPP treatment per-protocol; VIA Viabahn endoprosthesis; WIQ walking impairment questionnaire; Cardiovascular system; Femoral artery; Implants; Clinical trials; Risk factors; X 24310:Pharmaceuticals